Navigation Links
Beckman Coulter's 4th Quarter and Full Year 2007 Revenue Grows 10.8% and 9.2%, Respectively; 2007 Earnings Per Share Beat Outlook
Date:2/8/2008

net earnings $69.6 $1.08 $65.8 $1.03

Year Ended December 31,

2007 2006

Amount Per Amount Per

Diluted Diluted

Share Share

GAAP net earnings $211.3 $3.30 $186.9 $2.92

Reconciling items:

Biosite break-up fee(a) (40.6) (0.64) - -

Rental tax dispute(b) 2.4 0.04 - -

NexGen acquisition(c) 35.4 0.55 - -

Beckman Coulter

Foundation(e) 9.0 0.14 - -

Miami vacant land

sale(d) (26.2) (0.41) - -

Supply chain

relocation(f) 16.9 0.28 - -

Impairment charges(h) 0.8 0.01 2.3 0.04

Discontinued operation

(APG)(g) (1.6) (0.03) (28.7) (0.45)

Restructuring related

charges(h) - - 13.2 0.20

Roche research and

development charge(i) - - 27.5 0.43

Pension curtailment(j) - - 4.0 0.06

Applera settlement(k) - - (16.1) (0.25)

Investigation charges(l) - - 2.9 0.05

Debt extinguishment(m) - - 7.7 0.12

Adjustment for income

taxes 0.9 0.01 (15.6) (0.24)

Adjusted net earnings $208.3 $3.25 $184.1 $2.88

See "Non-GAAP Financial Measures," where the impacts of certain
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine news :

1. Beckman Coulter Announces Licensing Option Agreements for Cancer Genes with Johns Hopkins University
2. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
3. Beckman Coulter to Present at the Credit Suisse Global Healthcare Conference
4. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
5. Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference
6. Haemacure Reports Third Quarter 2007 Results
7. Weight Watchers Declares Quarterly Dividend
8. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
9. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
10. Medical Services International Maintains Pace in Second Quarter
11. Martek Announces Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ersity College of Medicine research team led by Ya...of regulation in the cell division cycle, which co...cer begins. , Wang, an assistant professor of bi... the findings will lead to an improved ability to ...w drugs that kill cancer cells by inhibiting cell ...
(Date:11/21/2008)... -- The Providence Service,Corporation (Nasdaq: ...Company,s,Chief Operating Officer, has been appoi...rris, appointment fills the vacancy left by the Ap...turns the board to six members. Mr.,Norris will ...Mr. Norris, age 41, has been with Providence since...
(Date:11/21/2008)...ue to combat cancer, study says, , , ...chers have discovered that some cancer cells use l...ht lead to new treatments that starve and kill the...ls in the body need to produce energy. They do thi...res oxygen. Compared with normal cells, tumor cell...
(Date:11/21/2008)...ct Investment And Restore Shareholder Value , ...- Dr. Stephen Joffe, Craig Joffe, and Alan Buckey ...h the U.S. Securities and Exchange Commission. Th...p of 11.4% of LCA-Vision, Inc. (Nasdaq: LCAV ), ...n correction centers in 33 states in the United St...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...the women, who received cognitive behavioral thera... for suicide. Women given cognitive behavioral th...en who were treated by expert therapists - said Ma...e study. In addition, the women who received the...
...herside Hospital is being investigated by the Gard...r she apparently became caught in the straps of he...ting with the investigation and will launch its ow...lity in Cork. The HSE added that the hospital has ...
...a tentative New Drug Approval from USFDA for its f...V-1 infection//. The new drug approval is for fi...udine, Zidovudine, Nevirapine tablets used in the ...n, the company informed the Bombay Stock Exchange....
...njecting cattle with many growth hormones that are...ncern among EU nations that import beef, necessita...ment expert and a pharmaceutical chemist, John Ver...effects of consuming beef from cattle that have be...
Other Medicine News:Health News:Special Behavioral Therapies made Women more likely to Attempt Suicide 2Health News:Special Behavioral Therapies made Women more likely to Attempt Suicide 3
(Date:11/19/2008)...CHELLE, N.Y., Nov. 19 Biotech scie...gies to toxicology research to better understand t...f organ systems, reports Genetic Engineering &... interested in figuring out a new compound,s mecha...ive toxicology technique, according to the Novembe...
(Date:11/18/2008)..., November 19 NeuroDisco...vice provider and drug development Company,and S...: 4565), a leading,international biopharmaceutica...presenting further pivotal pre-clinical efficacy d...is a potential therapy for neuropathic pain and ha...
(Date:11/18/2008)...WNE, Va., Nov. 18 Forty...ered at a November national forum to consider cutt...lic health and national economy from outbreaks of ...nced today. , , Among those innovations: ,... American kitchen table that detects highly contag...
(Date:11/13/2008)...DFORD, Mass., Nov. 13 Ho... manufacturer and supplier of premium,diagnostics,...icated to,serving the healthcare needs of women, t...h-risk pivotal clinical trial. The Cervista HPV hi...in the U.S. and is expected to be,launched in the ...
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4John H Flood III Named as CEO of Flagship Global Health Inc 6813 1John H Flood III Named as CEO of Flagship Global Health Inc 6813 2NxStage Medical Establishes 2450 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital 6811 1NxStage Medical Establishes 2450 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital 6811 2NxStage Medical Establishes 2450 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital 6811 3Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference 1909 1Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference 1909 2Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference 1909 3Zimmer Holdings Announces Support for Elimination of Super Majority Voting Requirements 1907 1Zimmer Holdings Announces Support for Elimination of Super Majority Voting Requirements 1907 2Zimmer Holdings Announces Support for Elimination of Super Majority Voting Requirements 1907 3
...uable Patients Receiving Combination of,Bavituxima...r Response or Stable Disease - , - 75% of Patie...itabine , ,Achieved Objective Tumor Resp...nts Receiving Combination of Bavituximab Plus , ...umor Response - , - Trial Results Support Ad...
...nd GAITHERSBURG, Md., May 31, 2007 (PRIME,NEWSWIRE...and,MedImmune, Inc. (Nasdaq:MEDI) today announced ... trial in patients with,gastrointestinal stromal t... will be presented at the 2007 Annual Meeting of t...o be held June 1-5,2007 at McCormick Place in Chi...
Other Medicine Technology:Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 2Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 3Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 4Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 5Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 2Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 3Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 4Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 5
... gives you the detailed information you need to ma...ents with palpitations, syncope and intermittent c...em, this transtelephonic cardiac event monitor req... ECG. Comfortable for your patients to wear and si...
...ATION enhances patient care management by providin...port, and clinical reporting from anywhere in the ...System, the MULTIVIEW WORKSTATION provides compreh...real-time patient vital signs and hemodynamics, re...
The biograph 2 offers the ultimate PET/CT performance for improved disease diagnosis and treatment in oncology, neurology, and cardiology. It delivers high-quality PET/CT whole body scans in less tha
... the highly respected single-source CT solution, f...alizing plaque. With its proprietary STRATON X-ray...tion time of 0.33s, virtually freezing the hearts ...he system delivers unprecedented diagnostic detail...
Medicine Products: